Zehui Biotechnology
PrivateLast Round
Series B
Mar 1, 2023
Est. Valuation
$327.56M
Total Funding Raised
$83.14M
Company Overview
Zehui Biotechnology operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B round in March 2023.
Zehui Biotechnology is a biopharmaceutical company that develops innovative cell therapy products derived from pluripotent stem cells to treat various diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zehui Biotechnology Comparables
Compare Zehui Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Guangzhou Saijun Biotechnology Co., Ltd. | 84% | |
| Help Therapeutics | 80% | |
| iRegene Therapeutics | 79% |
For institutional investors. Book with your work email.
Zehui Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 1, 2023 | ||||
| VC Round | Apr 1, 2021 | ||||
| Series A | Dec 1, 2020 | ||||
| Angel | Sep 1, 2019 |
For institutional investors. Book with your work email.
Zehui Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bencao Capital | VC Round |
| Guokejiahe Fund | VC Round |
| CAS Star | Angel |
| CCB Trust Co., Ltd. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2020
$24M round led by Beijing Guoke Dingzhi Equity Investment Center.
- Sep 1, 2019
$14M raised from CAS Star.
For institutional investors. Book with your work email.
Zehui Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zehui Biotechnology's valuation, stock price, and market status.
Is Zehui Biotechnology a public or private company?
Zehui Biotechnology is a private company.
What is the current stock price of Zehui Biotechnology?
Zehui Biotechnology is a private company, so its shares have no public market price. Caplight tracks Zehui Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zehui Biotechnology worth (valuation)?
Zehui Biotechnology's valuation is estimated at $327.6M based on funding round data.
Can I buy Zehui Biotechnology stock?
Zehui Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zehui Biotechnology's last funding round?
Zehui Biotechnology's most recent funding round was Series B on March 1, 2023.
Who are the main investors in Zehui Biotechnology?
Key investors in Zehui Biotechnology include CCB Trust Co., Ltd..
Will Zehui Biotechnology IPO soon?
No public IPO plans have been announced for Zehui Biotechnology.
How can I track Zehui Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Zehui Biotechnology's shares on secondary markets.